Skip to content
HomeThe Road to a Vaccine

The Road to a Vaccine: A New York City doctor shares what he’s learned about COVID-19

In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 8 of The Road to a Vaccine, Dr. Matt McCarthy shares with Lisa Ling how he believes mask wearing, social distancing and good science have helped lower COVID-19 rates in NYC. And Dr. Paul Stoffels gives an update on the scientific community’s latest coronavirus news.

Note: This program originally aired on Oct. 6, 2020.
RTAV: Season 2, Episode 8
Lisa Ling (left) smiling and having a discussion with Matt McCarthy, M.D. (right)

Lisa Ling

Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
Glenda Gray, CEO and president, South African Medical Research Council, and chair of the Imbokodo study

Glenda Gray, MBBCH

Dr. Gray is the President and CEO of the South African Medical Research Council (SAMRC); co-founder of the internationally-recognized Perinatal HIV Research Unit in Soweto, South Africa; co-PI of the HIV Vaccine Trials Network (HVTN) and Director of HVTN Africa Programs.
RTAV Headshot - Matt McCarthy, M.D.

Matt McCarthy, M.D.

Dr. McCarthy is a physician, researcher and best-selling author of three books, including the international bestseller, Superbugs: The Race to Stop an Epidemic. He has served as a pandemic advisor to the United States Army, New York City public schools and both Republican and Democratic congressmen.

Paul Stoffels, M.D.

Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company’s sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.

Caring on the COVID-19 front lines: “I took a leave from my job to treat some of the sickest patients in an ICU”

If you could help those most critically ill with the novel coronavirus, would you? Employee and trained nurse Laura Gador jumped at the chance to volunteer at a hospital in Hamburg, Germany—and is sharing her hardships and triumphs, and what’s giving her strength.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.